Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Structure-Activity Relationships and Drug Design

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence its...

Drug Discovery: Overview

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...

Pharmacogenomics: Identification of New Drug Targets

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...

Dosage Regimen: Individualization

Dosage Regimen: Individualization

Individualization in dosing regimens is the customization of medication doses for individual patients. Its necessity arises from the goal of maximizing therapeutic benefits while minimizing risks. This approach is pivotal because human responses to drugs can vary widely; what is effective for one person may be inadequate or excessive for another. Interpatient (intersubject) variability refers to differences in drug responses between individuals, while intrapatient (intrasubject) variability...

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Biopharmaceutical Factors Influencing Drug Product Design: Overview

Rational drug product design integrates knowledge of the drug’s physicochemical properties, formulation components, manufacturing techniques, and intended route of administration. Each factor influences the drug’s performance, including how it is released, absorbed, and eliminated in the body.The physicochemical properties of a drug—such as solubility, stability, and particle size—affect its compatibility with excipients and the choice of dosage form. Excipients, though pharmacologically...

Dose-Response Relationship: Selectivity and Specificity

Dose-Response Relationship: Selectivity and Specificity

Drugs exert their therapeutic effects by interacting with receptors, enzymes, or ion channels that are present throughout the human body. The strength and duration of the interaction between a drug and its target receptor are characterized by the selectivity and specificity of the drug. Selectivity refers to a drug's strong preference for its intended target over other targets. For instance, isoprenaline, a non-selective β-adrenergic agonist, interacts with both β1- and β2-adrenergic receptors...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

TRPV4: A Promising Therapeutic Target Ion Channel─Discovery of Ultrapotent Selective Antagonists.

Journal of medicinal chemistry·2026

Same author

Linker-Driven Sampling of PROTAC-Induced Ternary Complexes.

Journal of medicinal chemistry·2026

Same author

Exploring Secondary Structure Predictions for RNA-Targeted Drug Discovery: Power and Challenges.

Journal of chemical information and modeling·2026

Same author

PROTAC-Splitter: a machine learning framework for automated identification of PROTAC substructures.

Journal of cheminformatics·2026

Same author

Correction: Enhanced Thompson sampling by roulette wheel selection for screening ultralarge combinatorial libraries.

Journal of cheminformatics·2025

Same author

Enhanced Thompson sampling by roulette wheel selection for screening ultralarge combinatorial libraries.

Journal of cheminformatics·2025

Search research articles

Related Experiment Video

Updated: Jun 5, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Exploiting personalized information for reagent selection in drug design.

Jonas Boström¹, Niklas Falk, Christian Tyrchan

¹Lead Generation Department, AstraZeneca R&D Mölndal, S-43183 Mölndal, Sweden. jonas.bostrom@astrazeneca.com

Drug Discovery Today

|January 26, 2011

Summary

This study introduces recommender systems for chemical reagent selection in drug discovery. The aim is to enhance drug design by openly sharing information and facilitating serendipitous discoveries.

More Related Videos

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Related Experiment Videos

Last Updated: Jun 5, 2026

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Drug Repurposing Hypothesis Generation Using the "RE:fine Drugs" System

Published on: December 11, 2016

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions

Published on: December 1, 2020

Area of Science:

Drug discovery and development
Computational chemistry
Information science

Background:

Industrialization of drug discovery contrasts with the information age.
Chemical reagent selection is a critical aspect of drug design.
Existing methods may limit chemists' considerations.

Purpose of the Study:

Introduce a recommender system concept for chemical reagent selection.
Develop an infrastructure to support this concept.
Facilitate open information transfer to aid drug design.

Main Methods:

Leveraging recommender systems technology.
Integrating a corporate reagent database.
Designing a system to highlight novel reagent options.

Main Results:

A novel approach for chemical reagent selection in drug discovery.
A system designed to broaden chemists' perspectives.
Potential to increase intuition and serendipity in the design process.

Conclusions:

Recommender systems offer a valuable tool for modern drug discovery.
Open information sharing can significantly impact reagent selection.
The proposed infrastructure can enhance the efficiency and creativity of drug design.